Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.

ClinicalTrials.gov ID: NCT00101686

Public ClinicalTrials.gov record NCT00101686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-Center Phase III Trial Of Irinotecan In Combination With Three Different Methods Of Administration Of Fluoropyrimidine: Infusional 5-FU (FOLFIRI), Modified-Bolus 5-FU (Day 1 & 8), And Oral Capecitabine (Day 1-14); With Celecoxib Versus Placebo As First-Line Treatment For Patients With Metastatic Colorectal Cancer Study Amended April 23, 2004 To Include Bevacizumab

Study identification

NCT ID
NCT00101686
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
547 participants

Conditions and interventions

Interventions

  • Modified Bolus 5-FU/LV with Irinotecan Drug
  • FOLFIRI + bevacizumab Drug
  • miFL + bevacizumab Drug
  • Infusional 5-FU/LV with Irinotecan Drug
  • Oral Capecitabine with Irinotecan Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2003
Primary completion
Sep 30, 2008
Completion
Sep 30, 2008
Last update posted
Jan 11, 2010

2003 – 2008

United States locations

U.S. sites
141
U.S. states
37
U.S. cities
126
Facility City State ZIP Site status
Pfizer Investigational Site Birmgingham Alabama 35205
Pfizer Investigational Site Birmingham Alabama 35205
Pfizer Investigational Site Birmngham Alabama 35211
Pfizer Investigational Site Mobile Alabama 36608
Pfizer Investigational Site Flagstaff Arizona 86001
Pfizer Investigational Site Sedona Arizona 86336
Pfizer Investigational Site Tucson Arizona 85712
Pfizer Investigational Site Hot Spring Arkansas 71913
Pfizer Investigational Site Springdale Arkansas 72764
Pfizer Investigational Site Arroyo Grande California 93420
Pfizer Investigational Site Fountian Valley California 92708
Pfizer Investigational Site Fresno California 93710
Pfizer Investigational Site Los Gatos California 95032
Pfizer Investigational Site Mission Hills California 91345
Pfizer Investigational Site Modesto California 95355
Pfizer Investigational Site Orange California 92868
Pfizer Investigational Site Oxnard California 93030
Pfizer Investigational Site San Diego California 92123
Pfizer Investigational Site San Jose California 95125
Pfizer Investigational Site Boulder Colorado 80304
Pfizer Investigational Site Norwalk Connecticut 06581
Pfizer Investigational Site Stamford Connecticut 06902-3628
Pfizer Investigational Site Washington D.C. District of Columbia 20007
Pfizer Investigational Site Altamonte Springs Florida 32701
Pfizer Investigational Site Hollywood Florida 33021
Pfizer Investigational Site Lauderhill Florida 33319
Pfizer Investigational Site Miami Florida 33133
Pfizer Investigational Site Miami Beach Florida
Pfizer Investigational Site New Port Richey Florida 34652
Pfizer Investigational Site Ocala Florida 34474
Pfizer Investigational Site Sarasota Florida 34239
Pfizer Investigational Site Tamarac Florida 33321
Pfizer Investigational Site Macon Georgia 31201
Pfizer Investigational Site Niles Illinois 60714
Pfizer Investigational Site Rockford Illinois 61108-2472
Pfizer Investigational Site Skokie Illinois 60077
Pfizer Investigational Site Fishers Indiana 46038
Pfizer Investigational Site Fort Wayne Indiana 46815
Pfizer Investigational Site Terre Haute Indiana 47802
Pfizer Investigational Site Overland Park Kansas 66210
Pfizer Investigational Site Alexandria Louisiana 71301
Pfizer Investigational Site Shrevport Louisiana 71101
Pfizer Investigational Site Bangor Maine 04401
Pfizer Investigational Site Annapolis Maryland 21401
Pfizer Investigational Site Boston Massachusetts 02114
Pfizer Investigational Site Boston Massachusetts 02115
Pfizer Investigational Site Boston Massachusetts 02215
Pfizer Investigational Site Burlington Massachusetts 01805
Pfizer Investigational Site Pittsfield Massachusetts 01201
Pfizer Investigational Site Grand Rapids Michigan 49603
Pfizer Investigational Site Burnsville Minnesota 55337
Pfizer Investigational Site Robbinsdale Minnesota 55422
Pfizer Investigational Site Columbia Missouri 65201
Pfizer Investigational Site Columbia Missouri 65203
Pfizer Investigational Site Joplin Missouri 64804
Pfizer Investigational Site St Louis Missouri 63136
Pfizer Investigational Site St Louis Missouri 63141
Pfizer Investigational Site Billings Montana 59101
Pfizer Investigational Site Omaha Nebraska 68131
Pfizer Investigational Site Las Vegas Nevada 89109
Pfizer Investigational Site Hooksett New Hampshire 03106
Pfizer Investigational Site Lebanon New Hampshire 03756-0001
Pfizer Investigational Site Nashua New Hampshire 03060
Pfizer Investigational Site Summit New Jersey 07901
Pfizer Investigational Site Albuquerque New Mexico 87109
Pfizer Investigational Site Farmington New Mexico 87401
Pfizer Investigational Site Santa Fe New Mexico 87501
Pfizer Investigational Site Albany New York 12208
Pfizer Investigational Site Manhaset New York 11030
Pfizer Investigational Site Rockville Centre New York 11570
Pfizer Investigational Site Asheville North Carolina 28801
Pfizer Investigational Site Cary North Carolina 27511
Pfizer Investigational Site Fayetteville North Carolina 28302-2000
Pfizer Investigational Site Greensboro North Carolina 27403
Pfizer Investigational Site Hendersonville North Carolina 28791
Pfizer Investigational Site Hickory North Carolina 28602
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Winston-Salem North Carolina 27157
Pfizer Investigational Site Columbus Ohio 43215
Pfizer Investigational Site Dayton Ohio 45409
Pfizer Investigational Site Bartlesville Oklahoma 74006
Pfizer Investigational Site Norman Oklahoma 73071
Pfizer Investigational Site Oklahoma City Oklahoma 73104
Pfizer Investigational Site Eugene Oregon 97401
Pfizer Investigational Site Portland Oregon 97213
Pfizer Investigational Site Abington Pennsylvania 19001
Pfizer Investigational Site Philadelphia Pennsylvania 19014-4283
Pfizer Investigational Site Philadelphia Pennsylvania 19107
Pfizer Investigational Site Philadelphia Pennsylvania 19141
Pfizer Investigational Site Reading Pennsylvania 19603
Pfizer Investigational Site Chattanooga Tennessee 37404
Pfizer Investigational Site Collierville Tennessee 38017
Pfizer Investigational Site Germantown Tennessee 38138
Pfizer Investigational Site Jackson Tennessee 38301
Pfizer Investigational Site Knoxville Tennessee 37916
Pfizer Investigational Site Knoxville Tennessee 37920
Pfizer Investigational Site Abilene Texas 79606-5208
Pfizer Investigational Site Arlington Texas 76012
Pfizer Investigational Site Austin Texas 78705
Pfizer Investigational Site Austin Texas 78731
Pfizer Investigational Site Beaumont Texas 77702-1449
Pfizer Investigational Site Bedford Texas 76022
Pfizer Investigational Site Dallas Texas 75230-2510
Pfizer Investigational Site Dallas Texas 75231-4400
Pfizer Investigational Site Dallas Texas 75237
Pfizer Investigational Site Dallas Texas 75246
Pfizer Investigational Site Denton Texas 76210
Pfizer Investigational Site El Paso Texas 79902
Pfizer Investigational Site El Paso Texas 79915
Pfizer Investigational Site Fort Worth Texas 76104
Pfizer Investigational Site Fredericksburg Texas 78624-3847
Pfizer Investigational Site Garland Texas 75042
Pfizer Investigational Site Houston Texas 77030
Pfizer Investigational Site Houston Texas 77054
Pfizer Investigational Site Irving Texas 75061-224
Pfizer Investigational Site Lewisville Texas 75067
Pfizer Investigational Site Longview Texas 75601
Pfizer Investigational Site McAllen Texas 78503
Pfizer Investigational Site Mesquite Texas 75050
Pfizer Investigational Site Midland Texas 79701
Pfizer Investigational Site New Braunfels Texas 78130
Pfizer Investigational Site Odessa Texas 79761
Pfizer Investigational Site Paris Texas 75460
Pfizer Investigational Site Sherman Texas 75090-0504
Pfizer Investigational Site Temple Texas 76508
Pfizer Investigational Site Tyler Texas 75701-2001
Pfizer Investigational Site Tyler Texas 75702
Pfizer Investigational Site Waco Texas 76712
Pfizer Investigational Site Webster Texas 77598
Pfizer Investigational Site Wichita Falls Texas 76310
Pfizer Investigational Site Colchester Vermont 05446
Pfizer Investigational Site Fairfax Virginia 22031
Pfizer Investigational Site Newport News Virginia 23606
Pfizer Investigational Site Roanoke Virginia 24014
Pfizer Investigational Site Edmonds Washington 98026
Pfizer Investigational Site Lacy Washington 98503
Pfizer Investigational Site Seattle Washington 98133
Pfizer Investigational Site Spokane Washington 99202
Pfizer Investigational Site Yakima Washington 98902
Pfizer Investigational Site Glendale Wisconsin 53212
Pfizer Investigational Site Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00101686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2010 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00101686 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →